Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Projan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Francis Tally and the discovery and development of tigecycline: a personal reminiscenceSteven J Projan
Current Opinion in Microbiology|October 24, 2003
Why is big Pharma getting out of antibacterial drug discovery?Steven J Projan
Current Opinion in Pharmacology|September 27, 2002
New (and not so new) antibacterial targets - from where and when will the novel drugs come?Steven J Projan
Current Opinion in Microbiology|October 24, 2007
Late stage antibacterial drugs in the clinical pipelineSteven J Projan, Patricia A Bradford
Current Opinion in Pharmacology|July 28, 2006
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Steven J Projan, Mirjana Nesin, Paul M Dunman
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNAGesine Bauer, Christian Berens, Steven J Projan, et al.
Expert Opinion on Biological Therapy|July 23, 2004
Small molecules for small minds? The case for biologic pharmaceuticalsSteven J Projan, Davinder Gill, Zhijian Lu, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilisMelissa A Visalli, Ellen Murphy, Steven J Projan, et al.
Molecular Microbiology|April 1, 2006
Characterization of the Staphylococcus aureus CidR regulon: elucidation of a novel role for acetoin metabolism in cell death and lysisSoo-Jin Yang, Paul M Dunman, Steven J Projan, et al.
Journal of Bacteriology|February 18, 2006
Transcription Profiling of the mgrA Regulon in Staphylococcus aureusThanh T Luong, Paul M Dunman, Ellen Murphy, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Francis Tally and the discovery and development of tigecycline: a personal reminiscenceSteven J Projan
Current Opinion in Microbiology|October 24, 2003
Why is big Pharma getting out of antibacterial drug discovery?Steven J Projan
Current Opinion in Pharmacology|September 27, 2002
New (and not so new) antibacterial targets - from where and when will the novel drugs come?Steven J Projan
Current Opinion in Microbiology|October 24, 2007
Late stage antibacterial drugs in the clinical pipelineSteven J Projan, Patricia A Bradford
Current Opinion in Pharmacology|July 28, 2006
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Steven J Projan, Mirjana Nesin, Paul M Dunman
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNAGesine Bauer, Christian Berens, Steven J Projan, et al.
Expert Opinion on Biological Therapy|July 23, 2004
Small molecules for small minds? The case for biologic pharmaceuticalsSteven J Projan, Davinder Gill, Zhijian Lu, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilisMelissa A Visalli, Ellen Murphy, Steven J Projan, et al.
Molecular Microbiology|April 1, 2006
Characterization of the Staphylococcus aureus CidR regulon: elucidation of a novel role for acetoin metabolism in cell death and lysisSoo-Jin Yang, Paul M Dunman, Steven J Projan, et al.
Journal of Bacteriology|February 18, 2006
Transcription Profiling of the mgrA Regulon in Staphylococcus aureusThanh T Luong, Paul M Dunman, Ellen Murphy, et al.
Pageof 3